The N-myc proto-oncogene is expressed in many organs of the mouse embryo, suggesting that it has multiple functions. A null mutation leads to mid-gestation lethality [1-4], obscuring the later roles of the gene in organogenesis. We have generated a multi-purpose gene alteration by combining the potential for homologous and site-specific recombination in a single targeting vector, and using the selectable marker for neomycin-resistance, neo, to downregulate gene activity. This allowed us to create a series of alleles that led to different levels of N-myc expression. The phenotypes revealed a spectrum of developmental problems. The hypomorphic allele produced can be repaired in situ by Cre-recombinasemediated DNA excision. We show here for the first time the use of a single targeting vector to generate an allelic series. This, and the possibility of subsequent lineagespecific or conditional allele repair in situ, represent new genome modification strategies that can be used to investigate multiple functions of a single gene. 
Results and discussion
The targeting vector ( Figure 1a ) was designed to have a dual function: first to introduce a point mutation into the N-myc gene that leads to a null mutation, and second to create a Cre-recombinase-repairable hypomorphic N-myc allele. The 3′ homology arm of the targeting vector was used to engineer two point mutations: one changed the first leucine of the leucine zipper to proline (L423P), generating an inactive protein; the other (22 bp downstream) was neutral, creating a new site for the restriction enzyme PvuII. Depending on the recombination site (Figure 1b) , the mutations may or may not be co-introduced. Of the 12 homologous recombinant cell lines, three contained the new PvuII site (Figure 1d ). The presence of the L423P mutation was confirmed by sequencing. This allele was named N-myc Pneo (Figure 1c ). In the remaining lines, only the neo marker was inserted (N-myc Lneo allele, Figure 1c,d ). Transient expression of Cre recombinase in these lines resulted in excision of neo, by site-specific recombination between the loxP sites in an average of 1 in 29 colonies (Figure 1f ), thereby generating two more alleles: N-myc Plox from N-myc Pneo , and N-myc Llox from N-myc Lneo (Figure 1e ). The N-myc Llox allele is functionally equivalent to wild type, suggesting that the intronic loxP insertion allowed normal gene function.
The N-myc Plox and N-myc Pneo alleles had identical phenotypes; therefore data were pooled. In the F1 generation, kinks were observed in the proximal part of the tail because of vertebral fusion, with 25% penetrance in an outbred and 100% penetrance in an inbred (strain 129) background. Homozygous F2 embryos died at 11.5 days post coitum (dpc) and had the same phenotypes as the N-myc null alleles [1] [2] [3] [4] . Loss of function was due to altered protein activity and not to altered transcript levels, as equal levels of transcript from both mutant and wildtype (wt) alleles (Figure 2a , lanes 4-6) were detected by an allele-specific transcription assay (ASTA).
Homozygotes for the N-myc Lneo allele were viable, but had a vertebral fusion phenotype that was slightly more severe than that observed in heterozygotes for the N-myc Plox allele. As detected by ASTA (Figure 2a) , there was a 60% decrease in representation of the neo-containing allele in 9.5 dpc embryos in both the N-myc Pneo /wt (lanes 2,3) and N-myc Lneo /N-myc Plox (lanes 7,8) lines. Interestingly, we identified an alternative, aberrant splice product derived from the N-myc Lneo allele. Exon 2 was spliced to 5 bp 5′ of the neo ATG. At 15 bp 3′ of the neo stop codon, the transcript was spliced back to exon 3 ( Figure 2b) . A putative fusion protein from this mRNA would lack exon 3, which encodes the basic helix-loop-helix domain that is essential for biological activity, and would therefore act as an N-Myc protein null. This intronic interference is similar in nature to that recently reported for an FGF8 alteration [5] .
N-myc Lneo /N-myc Plox compound heterozygous embryos having 20% functional N-Myc levels were produced. These hypomorphs died at term because of a failure to initiate breathing. Lung development was compromised (Figure 3a) , as was observed in our earlier study [6] . In addition, the compact myocardium was extremely thin (Figure 3b ). By 12.5 dpc, N-myc Lneo /N-myc Plox embryos appeared smaller than the N-myc Lneo /wt littermates. The yolk sac of 15.5 dpc embryos had an opaque appearance (Figure 3d ) because of a deficiency in the remodeling of capillaries into larger vessels that normally results in a transparent yolk sac.
The length of the vertebral column was decreased by 40% (Figure 3c,f) , and a reduction in size of the vertebral bodies (Figure 3e ) was observed. In addition to vertebral fusion ( Figure 3f , green arrows), split ossification of vertebral bodies was observed (Figure 3f , yellow arrows), possibly a consequence of radial ossification suppression by the remnants of the notochord forming the intervertebral disks. Cartilage staining of 15.5 dpc embryos (Figure 3g ) supported the role of notochord in this phenotype. The small number of condensing chondrocytes appeared unable to entrap the notochord in segments of the vertebral column ( Figure 3h) ; thus the notochord did not regress (Figure 3h,i) . By 15.5 dpc, chondrocytes normally form clearly separated, highly condensed segments. At low levels of N-Myc, the boundaries of chondrocytes were not clearly defined, as separations were incomplete (Figure 3i ). The vertebral-fusion Single-vector targeting generates at least two alleles: the allele with the mutation and a hypomorphic allele. The first allows the study of the mutation, and the second allows the generation of a series of hypomorphic genotypes. As hypomorphic alleles created this way are repairable by Cre recombinase, lineage-specific gene repair may further facilitate the exploration of multiple gene functions. The strength of interference of an intronic insertion can be varied; for example, an inverted neo sequence encodes a cryptic splice acceptor site, and is stronger than when neo is in the same orientation [7, 8] . Therefore, this approach can be applied to genes requiring higher levels of interference to produce hypomorphs with informative phenotypes.
Materials and methods

Production of mutant alleles and embryos/animals
The targeting vector was electroporated into R1 embryonic stem (ES) cells [9] . Colonies were screened for homologous recombination by PCR and Southern analysis. At least two independent lines for each allele were introduced into the germ line. The Cre recombinase was transiently expressed in ES cells using standard electroporation conditions with pBS185 circular plasmid [10] . Mutant ES cells were aggregated with 8-cell-stage CD1 embryos. An hCMV-Cre transgenic mouse line (TgN(CMV-Cre)1AN) was produced by pronuclear injection of pBS185.
Measurement of the transcriptional activity of the modified N-myc allele N-myc Plox /wt, N-myc Lneo /N-myc Plox or N-myc Pneo /N-myc Llox 9.5 dpc embryos with only one PvuII-digestible allele served as templates for RT-PCR. PCR products were digested with PvuII and analyzed by Southern blotting using the purified PvuII-digested fragment as probe. This sequence was fully represented in both PvuII-digested and undigested bands. Band densities were measured using ImageQuant software (Molecular Dynamics).
Histology and skeletal preparation
Embryos were processed using standard procedures, sectioned at 7 µm and stained with hematoxylin and eosin. Skeletal preparations and cartilage staining were performed as previously described [11, 12] Supplementary Material 
Materials and methods
Design of targeting vector and targeting
A vector with loxP sites flanking the neo gene was created by replacing the LEU2 gene of the pBS67 plasmid [S1] with the PGK promoter-neo-PGK pA sequence from the pPNT vector [S2]. Using pN7.7 DNA [S3] as template, two point mutations were introduced into exon 3 of the N-myc gene by PCR-based mutagenesis. The first introduced mutation changed the codon for the leucine at a position 423 to a codon for proline. A neutral second point mutation was placed 22 bp 3′ of the first (at amino acid 430) thereby creating a novel PvuII site. A BamHI-BclI fragment of pN7.7 was used as a 5′ homology arm to the N-myc locus and a BclI-HincII fragment from the mutated genomic vector was used for the 3′ homology arm. These two fragments were placed on either side of the loxP-flanked neo cassette.
The neo gene was positioned in the same orientation as the N-myc gene. The tk gene from the pPNT vector was placed at the 3′ end of the 3′ homology arm of the targeting vector, providing a marker for negative selection (see Figure 1a ).
The targeting vector was electroporated into R1 ES cells [S4] as described previously [S5]
. Double-resistant colonies were screened by PCR (40 cycles, 94°C for 1 min, 57°C for 1 min, 72°C for 2 min, extension increased for 2 sec per cycle) using the following primers. Pr1: 5′-CTCGAGGGTTCGAAATCGGAT-3′ (polylinker sequence in the junction between the 3′ loxP site and intron 2); and Pr2: 5′-ACAAAACATCCCCCTCAAACA-3′ (an N-myc sequence lying outside of the targeting vector in the HincII-EcoRI region; see Figure  1b ). Candidate targeted lines were double-checked for correct homologous recombination at both ends by Southern blot analysis using EcoRI-digested DNA probed with the external EcoRI-BamHI fragment. The presence of the L423P mutation was confirmed by sequencing; this allele was named N-myc Lneo . The two possibilities for the recombination within the 3′ homology arm gave two different alleles (see Figure 1c ), which could be discriminated by PvuII digestion of the PCR products covering the putative mutated region of the targeted cell lines (see Figure 1d) .
Removal of the neo selectable marker by transient expression of the Cre recombinase in ES cells
To remove the neo selectable marker in vitro, 50 µg/ml pBS185 circular plasmid [S6] containing the cre gene driven by an hCMV promoter was electroporated into the N-myc Lneo and N-myc Pneo targeted ES cells. After electroporation, the cells were plated sparsely as single cells (1000 cells per 10 cm culture plate), resulting in 100-150 colonies per plate after a 7 day period. The colonies were screened by PCR for excision resulting in N-myc Llox and Nmyc Plox alleles (upper Pr3: 5′-TTTCTGCCACATCCTCAAGTT-3′, and lower: Pr4: 5′-CCC CGTGTCCTGCCCCCTACC-3′; both were N-myc sequences flanking the neo cassette insertion) (see Figure  1e) . The endogenous N-myc allele produced a 959 bp PCR product. The targeted allele should produce a 2992 bp fragment; however, because of its large size, no product was detected under our conditions. If the neo gene was excised, a 1040 bp product was amplified. Positive colonies were expanded, and the excision of neo was confirmed by checking the G418 sensitivity of the cell lines and by Southern blot analysis.
Direct injection of circular hCMV-Cre expression plasmid into the pronucleus
The pBS185 circular plasmid [S6] was directly injected at a concentration of 5 ng/µl into the pronucleus of F1 zygotes fertilized by germ-linetransmitting chimeric males. The action of Cre recombinase was tested by PCR on earpunch samples from animals that were born from these injected embryos. Two pairs of primers were used in the same amplification reaction: Pr7: 5′-ATCTCCTGTCATCTCACCTTGC-3′, and Pr8: 5′-ACCCCACCCCCACCCCCGTAG-3′, which amplify a 658 bp product from the neo-PGK pA junction; and Pr5: 5′-AGCATCTGT CGC-CAAGTCTAC-3′ and Pr6: 5′-TCCTCGTCATCCTCATCATCT-3′, which amplify the loxP insertion region and produce a product of 367 bp from the wild-type allele and a 459 bp sequence from the loxP-containing allele after the neo gene is removed. The conditions for the amplification were 94ºC for 1 min, 59ºC for 1 min and 72ºC for 3 min for 40 cycles.
Mating with a hCMV-cre transgenic mouse line
We created an hCMV-cre transgenic mouse line (TgN(CMV-Cre)1AN) by pronuclear injection of the cre-containing HindIII fragment of the pBS185 plasmid. This transgenic line was crossed with animals transmitting the neo-containing N-myc alleles (N-myc Pneo and N-myc Lneo ). The removal of the neo gene by site-specific recombination was tested among the offspring using the four-primer PCR screen described in the previous paragraph. As this four-primer system detects the presence of the neocontaining allele, the loxP-containing allele and wild-type alleles, it was used as a general screen in most of the genotypings. The presence of the cre transgene was tested in ear punch DNA by a three-primer PCR in which one of the upper primers (5′-CATTTCGTGATGAATGCCAC-3′) was specific for the cre gene, the other upper primer (5′-CCG-TAGCTCCAGCTTCAC C-3′) sequence was taken from the endogenous metallothionein (MT) gene and the common lower primer (5′-ACTTGCAGTTCTTGCAGG C-3′) from the MT poly(A) sequence, which is the polyadenylation signal for the cre transgene in pBS185. These primers normally create two products: a 668 bp band from the cre transgene and a 588 bp band from the endogenous MT gene at the PCR conditions: 94ºC for 1 min, 60ºC for 1 min, 72ºC for 1.5 min, for 35 cycles. However, our TgN(CMV-Cre)1AN transgenic line contains a high-copynumber cre transgene and, as a consequence, in the transgenic animals the amplification from the transgene compromises the amplification from the MT gene and only the 668 bp product was usually detected.
Transgenic lines expressing Cre recombinase and efficiency of excision
Approximately 90% of offspring inheriting the cre transgene from one of parents excised the selectable marker completely from the neo-containing allele. Excision was also complete in the germ line as these animals transmitted the neo-excised allele to the next generation. In contrast, offspring negative for the cre transgene retained the neo-containing allele. About 5% of the offspring inherited the cre transgene but no excision of the neo gene occurred. This indicates that, although the efficacy of the cre transgene is very high, it is not active in all embryos that inherit it. In the remaining 5% of the offspring mosaicism was observed.
The lck-cre transgenic mice were kindly provided by Junji Takeda. In this line of transgenic mice the Cre recombinase is expressed, and excises loxP-flanked sequences specifically in T cells. Within a few kilobase range the specific excision is complete (J. Takeda, personal communication).
Genotyping at the N-myc locus after germ-line transmission
After germ-line transmission, two pairs of primers were used in the same amplification reaction as for routine genotyping of N-myc. The primers 5′-ATCTCCTGTCATCTCACCTTGC-3′ and 5′-ACCCCA CCCCCACCCCCGTAG-3′ amplify a 658 bp product from the neo-PGK pA junction. The pair 5′-AGCATCTGTCGCCAAGTCTAC-3′ and 5′-TCCTCGTCATCCTCATCATCT-3′ amplify the loxP insertion region and produce a product of 367 bp from the wild-type allele, and 459 bp from the loxP-containing allele after the neo gene is removed.
Measurement of the transcriptional activity of the modified Nmyc allele by ASTA
The novel PvuII site, introduced into exon 3, allowed us to distinguish and compare the level of mRNA expression from the altered and the wild-type N-myc alleles in heterozygous embryos by PvuII digestion of an RT-PCR-amplified product across the mutations.
The effect of the transcriptional interference caused by the neo selectable marker inserted into intron 2 was measured using RNA from N-myc Pneo /wt embryos as a template. To exclude the possibility of any bias due to heterologous pairing between the two PCR products, which could result in a bias toward the PvuII-indigestible component, we also performed the measurement on N-myc Lneo /N-myc Plox 9.5 dpc embryos. In this genotype, the neo-inserted allele was PvuII indigestible. The same drop in representation of the neo-containing allele was observed in both situations, excluding any possible bias of the assay. Comparing the band densities, we estimated that the neo selectable marker placed in an intron and having the same orientation to the N-myc gene reduced mRNA expression by approximately 60%.
The ASTA on N-myc Pneo /wt and N-myc Lneo /N-myc Plox 9.5 dpc embryos showed the same 60% decrease in representation of the neo-containing allele. The level of decrease appears to be tissue independent as no statistically significant variation could be reproducibly detected from repeated ASTA performed on several organs at different embryonic stages.
For the RT-PCR, 5′-CGGTGGCTGCTCCTGCTCGTG-3′ as upper, and 5′-TGTCCTGCCCCCTACCCAGAT-3′ as lower primers were chosen from exon 2 and exon 3 of N-myc, respectively. The reverse transcriptase reaction was performed using the Ready-to-Go T-primed First-Strand Kit (Pharmacia). After RT the PCR was run for 35 cycles (95°C for 1 min, 60°C for 1 min, 72°C for 2 min). The PCR products were subsequently PvuII digested and analyzed by Southern blot using a purified PvuII-digested fragment from the above PCR product as probe. This sequence was fully represented in both PvuII-digested and undigested bands. The band densities were then measured using ImageQuant software (Molecular Dynamics).
In situ repair of the N-myc Lneo hypomorphic allele and rescue of N-myc Lneo /N-myc Plox perinatal lethal genotype
In situ rescue of the perinatal lethality of N-myc Lneo /N-myc Plox newborns by the Cre-recombinase-mediated excision of neo from the N-myc Lneo allele is shown in Figure S1a . This Cre-mediated excision rescued the perinatal lethal N-myc Lneo /N-myc Plox embryos by converting them to Nmyc Llox /N-myc Plox . A representative experiment is shown in Figure S1a . Of 35 Cre-positive animals, we found two N-myc Lneo /+ ( Figure S1b , offspring 5) and two mosaic N-myc Lneo /N-myc Plox ; N-myc Llox /N-myc Plox animals (data not shown), which indicated that, in 10% of the cases, the Cre-mediated excision was not complete or did not occur.
Additionally, an lck-promoter-driven cre transgenic line was used to demonstrate that the neo-derived transcriptional interference was repairable in a specific cell lineage, in this case T cells ( Figure S1c,  lanes 3,5,6 ). 
